Biotech Values

[DewDiligence]

Index to Main Documents in Copaxone Patent Litigation

[Updated for 8/24/11 entries; deleted obsolete documents.]


Please see #msg-54113660 for a list of the Copaxone patents being litigated.


The following documents are in reverse chronological order:

Summary of NVS/MNTA’s defense arguments
(8/24/11; 4 pages)

Court’s memorandum re claims construction and denial of MYL’s motion for summary judgment
(8/24/11; 51 pages; converted to text file via OCR software)

NVS/MNTA statement re molecular weight
(2/10/10; 4 pages; partially redacted)

NVS/MNTA motion for dismissal due to inequitable conduct
(2/9/10; 9 pages)

Teva’s reply to NVS/MNTA counterclaims
(12/8/08; 25 pages)

NVS/MNTA response and counterclaims to Teva’s complaint
(11/3/08; 50 pages)

Teva’s complaint of patent infringement
(8/28/08; 57 pages)